益生菌与功能成分的联合封装:设计策略,协同机制,生物医学应用以及工业化挑战
Chenyang Ji1, Danyuan Li2, Ying Liang2
1Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA. yangchao.luo@uconn.edu.
Journal of materials chemistry. B
|October 1, 2025
概括
联合封装通过将它们与有益的化合物相结合来增强益生菌的传递. 这一策略提高了治疗肠道健康问题和慢性疾病的生存率和疗效.
科学领域:
- 胃肠道学和微生物学
- 生物材料和药物输送
背景情况:
- 慢性疾病如IBD,糖尿病和结肠直肠癌与肠道功能障碍和屏障功能障碍有关.
- 益生菌显示治疗潜力,但患有低生存率和消化道的殖民.
- 益生菌与功能成分的联合封装是一种有前途的策略,可以克服输送限制.
研究的目的:
- 审查具有功能成分 (代谢物,益生菌,多醇) 的益生菌的联合封装策略.
- 检查益生菌联合封装的先进制造技术.
- 探索共同封装在慢性疾病干预中的应用潜力和挑战.
主要方法:
- 审查联合封装策略和先进的制造技术 (微流体,3D打印等). ) 的情况.
- 使用ex vivo模型,体内成像和代谢跟踪对功能性结果的评估.
- 分析慢性疾病干预中的应用,并确定扩大规模的挑战.
主要成果:
- 同封装显著提高了益生菌的生存率和功能稳定性.
- 先进的制造技术可以精确控制益生菌的输送和释放.
- 在治疗应用中增强益生菌疗效的证明优势.
结论:
- 益生菌联合封装是一种可行的方法,可以提高肠道微生物群相关慢性疾病的治疗效果.
- 需要进一步的研究来应对工业扩展,安全和临床翻译方面的挑战.
- 这一审查为推动益生菌联合封装技术向临床应用提供了基础.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
174
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
174
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
147
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
147
Biopharmaceutical Factors Influencing Drug Product Design: Overview
212
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
212
Bioavailability Enhancement: Drug Permeability Enhancement
163
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
163
Microorganisms in Medicine and Therapeutics
908
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
908
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
262
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
262


